Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | NIDAN Nidan Laboratories And Healthcare Ltd. Pharma · SME | THYROCARE Thyrocare Technologies Limited Pharma · Micro | VIYASH Viyash Scientific Limited Pharma · Micro | METROPOLIS Metropolis Healthcare Limited Pharma · Micro |
|---|---|---|---|---|
| Final Score | 36 | 52 | 46 | 38 |
| Verdict | WATCHLIST | FAIR VALUE | FAIR VALUE | WATCHLIST |
| Style | WATCHLIST | Premium Compounder | Financial Turnaround | WATCHLIST |
| Piotroski | 6/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 20/30 | 0/30 | 2/30 | 0/30 |
| Growth | 4/25 | 12/25 | 14/25 | 8/25 |
| Quality | 0/20 | 20/20 | 5/20 | 9/20 |
| Balance Sheet | 8/15 | 8/15 | 12/15 | 9/15 |
| Cash Flow | 8/10 | 8/10 | 8/10 | 7/10 |
| Price | ₹14 | ₹549 | ₹260 | ₹534 |
| P/E | 11.10 | 54.20 | 56.30 | 56.50 |
| P/B | 0.28 | 14.89 | 3.86 | 7.34 |
| ROE | 2.55% | 28.40% | 11.00% | 13.80% |
| ROCE | 5.99% | 35.40% | 19.00% | 17.80% |
| Debt / Equity | 0.16 | 0.09 | 0.17 | 0.15 |
| FCF Yield | 8.87% | 2.18% | 2.13% | 1.15% |
| Dividend Y | — | 1.70% | — | 0.37% |
| Altman Z | 2.54 | 9.35 | 6.22 | 8.61 |
| Promoter % | 57.04% | 60.92% | 61.31% | 48.86% |
| Mkt Cap (₹Cr) | 19.50 | 8718.00 | 11247.00 | 11092.00 |
| Graham # | ₹35.05 | ₹92.08 | ₹78 | ₹122.73 |
| Fair PE | 5.4 | 23.5 | 42.0 | 8.7 |
| MoS % | -137.8% | -128.3% | -52.5% | -568.5% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startNIDAN30
THYROCARE56
VIYASH124
METROPOLIS25